Association of p73 and MDM2 Polymorphisms With the Risk of Epithelial Ovarian Cancer in Chinese Women

被引:35
作者
Kang, Shan [2 ]
Wang, Dong-Jie [2 ]
Li, Wan-Sheng [2 ]
Wang, Na
Zhou, Rong-Miao
Sun, Dong-Lan
Duan, Ya-Nan
Li, Shi-Zhen [2 ]
Li, Xiao-Fei [2 ]
Li, Yan [1 ]
机构
[1] Hebei Med Univ, Dept Mol Biol, Hebei Canc Inst, Hosp 4, Shijiazhuang 050011, Peoples R China
[2] Hebei Med Univ, Dept Obstet & Gynecol, Hosp 4, Shijiazhuang 050011, Peoples R China
关键词
p73; Murine Double Minute2; Single nucleotide polymorphism; Epithelial ovarian cancer; Risk; ACCELERATES TUMOR-FORMATION; P53 ARG72PRO POLYMORPHISM; LUNG-CANCER; PROMOTER POLYMORPHISM; GENETIC POLYMORPHISMS; COLORECTAL-CANCER; NO ASSOCIATION; BREAST-CANCER; G4C14-TO-A4T14; EXPRESSION;
D O I
10.1111/IGC.0b013e3181a130ab
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This study was to investigate the association of p73 G4C14-to-A4T14 and Murine Double Minute2 (MDM2) 309T/G, De11518+/- single nucleotide polymorphisms with the risk of epithelial ovarian cancer (EOC) in Chinese. Materials and Methods: This hospital-based case-control study included 257 ovarian cancer patients and 257 healthy women who were matched for age. p73 and MDM2 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism. Results: There were no significant differences in allele frequencies and genotype distributions of the p73 G4C14-to-A4T14 polymorphism between cases and control women (P = 0.55 and 0.20, respectively). The frequencies of the G allele of the MDM2 309T/G polymorphism were significantly lower in ovarian cancer cases (46.7%) than those in healthy controls (54.7%), there was a statistical difference between the 2 groups (P = 0.01). Compared with the TIT genotype, the G allelotype (T/G+G/G genotype) significantly decreased the risk of developing EOC (odds ratio, 0.65; 95% confidence interval, 0.44-0.97). Although MDM2 Dell518+/- genotypes and allele frequencies did not differ between the case and the control groups (P = 0.68 and P = 0.45), Del1518 +/+ genotype tended to increase the risk of mucinous ovarian cancer or earlier ovarian cancer by stratification analysis according to histological subtypes or clinical stage. Besides, there was a significant interaction between p 73 G4C14-to-A4T14 and MDM2 309T/G polymorphisms by the likelihood ratio test (P = 0.03; odds ratio, 0.89; 95% confidence interval, 0.80-0.99). Conclusion: The MDM2 SNP309G allele significantly decreased the risk of EOC and might be a potentially protective factor for EOC development in Chinese women.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 33 条
[1]   The MDM2 promoter polymorphism SNP309T→G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck [J].
Alhopuro, P ;
Ylisaukko-oja, SK ;
Koskinen, WJ ;
Bono, P ;
Arola, J ;
Järvinen, HJ ;
Mecklin, JP ;
Atula, T ;
Kontio, R ;
Mäkitie, AA ;
Suominen, S ;
Leivo, I ;
Vahteristo, P ;
Aaltonen, LM ;
Aaltonen, LA .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (09) :694-698
[2]  
Bak Mihaly, 1999, Orvosi Hetilap, V140, P1837
[3]   MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner [J].
Bond, Gareth L. ;
Hirshfield, Kim M. ;
Kirchhoff, Tomas ;
Alexe, Gabriella ;
Bond, Elisabeth E. ;
Robins, Harlan ;
Bartel, Frank ;
Taubert, Helge ;
Wuerl, Peter ;
Hait, William ;
Toppmeyer, Deborah ;
Offit, Kenneth ;
Levine, Arnold J. .
CANCER RESEARCH, 2006, 66 (10) :5104-5110
[4]   A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans [J].
Bond, GL ;
Hu, WW ;
Bond, EE ;
Robins, H ;
Lutzker, SG ;
Arva, NC ;
Bargonetti, J ;
Bartel, F ;
Taubert, H ;
Wuerl, P ;
Onel, K ;
Yip, L ;
Hwang, SJ ;
Strong, LC ;
Lozano, G ;
Levine, AJ .
CELL, 2004, 119 (05) :591-602
[5]   Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome [J].
Bougeard, G. ;
Baert-Desurmont, S. ;
Tournier, I. ;
Vasseur, S. ;
Martin, C. ;
Brugieres, L. ;
Chompret, A. ;
Bressac-de Paillerets, B. ;
Stoppa-Lyonnet, D. ;
Bonaiti-Pellie, C. ;
Frebourg, T. .
JOURNAL OF MEDICAL GENETICS, 2006, 43 (06) :531-533
[6]   No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer [J].
Campbell, Ian G. ;
Eccles, Diana M. ;
Choong, David Y. H. .
CANCER LETTERS, 2006, 240 (02) :195-197
[7]  
GIROD SC, 1995, ANTICANCER RES, V15, P1453
[8]   No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese [J].
Hamajima, N ;
Matsuo, K ;
Suzuki, T ;
Nakamura, T ;
Matsuura, A ;
Hatooka, S ;
Shinoda, M ;
Kodera, Y ;
Yamamura, Y ;
Hirai, T ;
Kato, T ;
Tajima, K .
CANCER LETTERS, 2002, 181 (01) :81-85
[9]   Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population [J].
Hu, ZB ;
Miao, XP ;
Mai, HX ;
Tan, W ;
Wang, XR ;
Lu, DR ;
Wei, QY ;
Lin, DX ;
Shen, HB .
INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (03) :455-460
[10]   Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population [J].
Hu, ZB ;
Ma, HX ;
Lu, DR ;
Qian, J ;
Zhou, JN ;
Chen, YJ ;
Xu, L ;
Wang, XR ;
Wei, QY ;
Shen, HB .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (05) :1275-1278